|
Index of reports
> Cases resulting in a serious event (100)
> Cases with Pulmonary Alveolar Haemorrhage (9)
Below is the selection of adverse event reports related to Tenormin (Atenolol) that includes cases resulting in a serious event where reactions include pulmonary alveolar haemorrhage.
Adverse event in male receiving Tenormin (Atenolol)
Reported by a physician from Japan on 2007-06-20
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Adverse event in male receiving Tenormin (Atenolol)
Reported by a physician from Japan on 2007-06-18
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Adverse event in male receiving Tenormin (Atenolol)
Reported by a physician from Japan on 2007-05-23
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-01-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Other drugs received by patient: Flomox; Kirpres; Mucosolvan; Medicon
Adverse event in male receiving Tenormin (Atenolol)
Reported by a physician from Japan on 2007-04-26
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-01-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Other drugs received by patient: Flomox; Kirpres; Mucosolvan; Medicon
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-03-27
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-02-22
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-02-22
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-02-08
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-01-19
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Suspect drug(s):
Micardis
Administration route: Oral
Norvasc
Administration route: Oral
Tenormin
Administration route: Oral
|
